首页 | 本学科首页   官方微博 | 高级检索  
   检索      


The variability of the harlequin mouse phenotype resembles that of human mitochondrial-complex I-deficiency syndromes
Authors:Bénit Paule  Goncalves Sergio  Dassa Emmanuel Philippe  Brière Jean-Jacques  Rustin Pierre
Institution:Inserm, U676, Hôpital Robert Debré, Paris, and Université Paris 7, Faculté de médecine Denis Diderot, IFR02, Paris, France.;Hospital Vall d′Hebron, Spain
Abstract:

Background

Despite the considerable progress made in understanding the molecular bases of mitochondrial diseases, no effective treatments have been developed to date. Faithful animal models would be extremely helpful for designing such treatments. We showed previously that the Harlequin mouse phenotype was due to a specific mitochondrial complex I deficiency resulting from the loss of the Apoptosis Inducing Factor (Aif) protein.

Methodology/Principal Findings

Here, we conducted a detailed evaluation of the Harlequin mouse phenotype, including the biochemical abnormalities in various tissues. We observed highly variable disease expression considering both severity and time course progression. In each tissue, abnormalities correlated with the residual amount of the respiratory chain complex I 20 kDa subunit, rather than with residual Aif protein. Antioxidant enzyme activities were normal except in skeletal muscle, where they were moderately elevated.

Conclusions/Significance

Thus, the Harlequin mouse phenotype appears to result from mitochondrial respiratory chain complex I deficiency. Its features resemble those of human complex I deficiency syndromes. The Harlequin mouse holds promise as a model for developing treatments for complex I deficiency syndromes.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号